In AD mouse models, BJT alleviated dermatitis symptoms and reduced blood immunoglobulin E (IgE) levels, demonstrating immunomodulatory effects (Ahn et al., 2023; Kobayashi et al., 2003; Suzuki et al., 1999). The gene discussed is IGHE; the disease is Alzheimer disease.